Eloralintide supplier/2883634-40-8/Peptide synthesis

Description

Eloralintide is a selective amylin receptor agonist composed of 39 amino acids, with potential for research in type 2 diabetes and obesity. Eloralintide has currently completed Phase II clinical trials and is set to enter Phase III clinical trials in December 2025.

Specifications

Apperance: White to off-white powder

Purity(HPLC): ≥98.0%

Single Impurity: ≤2.0%

Acetate Content(HPLC): 5.0%～12.0%

Water Content (Karl Fischer): ≤10.0%

Peptide Content: ≥80.0%

Packing and Shipping: Low temperature, vacuum packing, accurate to mg as required.

FAQ：

What packaging is used for my goods?

We usually use bottles made of PP material for packaging, and then cover the bottles with a layer of aluminum foil bags.

How is the solubility of peptides? 

The solubility of peptides is influenced by various factors, including amino acid sequence, charge, hydrophilicity and hydrophobicity, etc. When dissolving peptides, it is recommended to conduct a small-scale solubility test first, and after confirming complete dissolution, proceed with dilution. Go top bio provides solubility testing services.

If you want to do a biotin modification at the N terminal, do you need to put a gap between the biotin and the peptide sequence?

The standard biotin labeling procedure used by our company is to attach an Ahx to the peptide chain, followed by biotin. Ahx is a 6-carbon compound that acts as a barrier between the peptide and the biotin.

Are polypeptides harmful to humans?

Peptides, which are naturally present in the human body, are generally safe for use. However, some peptides may have specific pharmacological activities, and it is advisable to consult with a doctor or a professional before using them.